Nebol (Nebivolol Hydrochloride)

Nebivolol, the active ingredient in Nebol, is a beta blocker presented as an oral dosage form for oral use. It treats essential hypertension and may be used in heart failure management in adult patients. GNH USA supplies Nebol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nebivolol is used to manage conditions within the cardiovascular disease pathway, primarily hypertension and related disorders. - Essential hypertension: lowers systolic and diastolic blood pressure in patients with primary hypertension. - Heart failure with reduced ejection fraction: improves cardiac output and reduces mortality when added to standard therapy. - Isolated systolic hypertension in the elderly: helps control elevated systolic pressure and improves arterial compliance.

Nebivolol may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate pain often occurring early in therapy. - Dizziness or light‑headedness: related to blood pressure reduction. - Fatigue: feeling of tiredness or reduced energy. - Bradycardia: slower than normal heart rate. - Peripheral edema: mild swelling of ankles or feet. - Nasal congestion: stuffy nose without infection.

Serious or Rare Side Effects: - Severe bradycardia: markedly low heart rate requiring medical attention. - Symptomatic hypotension: sudden drop in blood pressure causing faintness. - AV block or heart block: impaired electrical conduction of the heart. - Bronchospasm: narrowing of airways, especially in patients with asthma. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Hepatic dysfunction: abnormal liver enzymes or jaundice.

Before initiating Nebivolol therapy, certain precautions should be observed. - Monitor blood pressure: check regularly to ensure therapeutic effect. - Assess heart rate: watch for excessive bradycardia, especially in patients with conduction disorders. - Caution in asthma or COPD: beta‑blockade may worsen bronchospasm. - Use carefully in diabetes: may mask hypoglycaemia symptoms. - Avoid abrupt discontinuation: taper dose to prevent rebound hypertension. - Store at room temperature: keep in original container, protect from moisture.

Nebivolol can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Combined with other beta‑blockers: risk of excessive bradycardia and hypotension. - Concomitant use with non‑dihydropyridine calcium channel blockers (verapamil, diltiazem): may cause severe AV block. - Potent CYP2D6 inhibitors (e.g., paroxetine, fluoxetine): increase nebivolol plasma concentrations.

Moderate Interactions (Monitor Closely): - NSAIDs: may attenuate antihypertensive effect. - Diuretics: can enhance hypotensive response. - Clonidine: abrupt withdrawal may precipitate rebound hypertension.